MetaCap

Glaukos Financial Ratios

NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD

165.69+4.40 (+2.73%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Glaukos ratio analysis

Glaukos earned a net margin of -37.0% in FY 2025, up from -38.2% a year earlier. Gross margin was 55.7% compared with a median of 77.3% over the prior 9 years. Return on equity reached -28.6%, meaning Glaukos generated -0.29 dollars of profit for every dollar of shareholders' equity.

Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Glaukos financial ratios (annual)

Glaukos annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)——————147.27——285.83
Price / sales12.4820.8312.237.337.0214.898.5910.335.549.87
Price / book9.6510.428.343.913.515.023.0210.776.389.63
Gross margin55.7%75.5%76.0%75.6%77.3%59.2%83.7%86.2%86.8%85.9%
Operating margin-39.3%-31.9%-40.9%-29.1%-11.2%-54.9%-21.2%-7.2%-1.4%3.7%
Net margin-37.0%-38.2%-42.8%-35.1%-16.9%-53.5%6.5%-7.1%-0.1%4.0%
Free cash flow margin-4.4%-17.6%-24.8%-22.4%-7.8%-13.3%-2.1%4.7%12.4%5.3%
Return on equity (ROE)-28.6%-19.1%-29.2%-18.7%-8.4%-18.0%2.3%-7.4%-0.1%3.9%
Return on assets (ROA)-21.0%-15.0%-14.3%-9.9%-4.7%-12.0%1.9%-6.3%-0.1%3.4%
Current ratio4.695.995.346.137.679.454.565.815.587.09
Revenue growth32.3%21.9%11.3%-3.8%30.7%-5.1%30.7%13.8%39.2%59.5%
EPS growth—————-829.7%——-100.0%—

Related